Hi mooers!
$Alphabet-A (GOOGL.US)$ is releasing its Q3 earnings on October 29 after the bell. Unlock insights with GOOGL Earnings Hub>>
$Alphabet-A (GOOGL.US)$'s stock price has risen 18.61% this year, as of October 25. Recently the company announced that they are developing AI technology that takes over a web browser to complete tasks. Interested in the management's announcement? Subscribe to @Moo Live and book the conferenc...

$Palantir (PLTR.US)$ let break $25 . be diamond hands . not paper hands .

$NIO Inc (NIO.US)$ $Li Auto (LI.US)$ $Coinbase (COIN.US)$ $Emeren Group (SOL.US)$ $Palantir (PLTR.US)$ $American Airlines (AAL.US)$
you know, pretty much all of them.  I don't have much money, so I can afford to take the losses, so I'm just hanging on with the hopes that I'll at least break even at some point

$Palantir (PLTR.US)$ Will it drop to usd18?

$Moderna (MRNA.US)$ stock gained 7.8% Thursday, its virtual R&D day, which began at 8 a.m. Eastern. It plans to announce the development of a vaccine candidate that will protect against Covid-19 and the flu, to be known as mRNA-1073. 
Moderna was a very different company at the time of its last virtual R&D day in September of 2020. Still a clinical-stage company at the time, Moderna had no authorized or approved products. That changed months later, when the U.S. Food and Drug Administration authorized Moderna’s Covid-19 vaccine, which is expected to bring in $20.1 billion in revenues this year alone.
Its stock price has been up more than 300% this year. 
Just to mention, another vaccine maker $Novavax (NVAX.US)$ had also initiated an early-stage study to test its combined flu and COVID-19 vaccine. However, the same scenario didn't show on its stock price. Kinda tricky.
Source: Moderna Stock Jumped Because It Just Unveiled a Two-in-One Vaccine for Covid and the Flu